Novel use of transoesophageal echocardiography in a pregnant patient undergoing neurosurgery Sir, Transoesophageal echocardiography (TEE) is a sensitive monitoring device used in neuroanaesthesia practice to detect venous air embolism and patent foramen ovale. In this article, we describe the extended use of the TEE probe for continuous monitoring of the foetal heart rate (FHR) of a pregnant patient undergoing neurosurgery.
A 25-year-old, 53 kg female in her 25 th week of pregnancy presented to the outpatient department with the chief complaints of headache and hearing loss on the right side for 6 months with gait ataxia with facial asymmetry for 2 months. She was diagnosed with a right cerebellopontine acoustic schwannoma of size 4 cm × 3.5 cm × 5.1 cm and was scheduled for resection in left lateral position. After obtaining written informed consent from the patient, abdominal ultrasound recorded before surgery revealed the presence of a live foetus of gestational age 25 weeks. During surgery, continuous FHR monitoring was done with the help of a transoesophageal echocardiography (TEE) probe attached to the abdominal wall of the patient [ Figure 1 ] since the ultrasonography Doppler machine was non-functional at that time. The foetal and maternal intraoperative haemodynamic or respiratory parameters were stable throughout the procedure. Obstetric evaluation was done throughout the Intensive Care Unit stay. Postoperatively, the patient had right-sided grade-3 facial nerve paresis that gradually improved with time. The patient underwent caesarean section under general anaesthesia at the 35 th week of her pregnancy and gave birth to a child with low Apgar scores at 1 min.
The pregnant patient presenting for neurosurgery is not uncommon and a search for contemporary literature regarding anaesthetic management yields both case reports [1] [2] [3] [4] and series, [5] but a definitive evidence-based guideline is still limited by traditional practices, lack of significant data and paucity of cases. Recent recommendations from the American College of Obstetricians and Gynecologists suggest that intraoperative foetal well-being monitoring may be appropriate in the presence of viable foetus, logistic support to perform foetal monitoring, trained qualified obstetrician to intervene intraoperatively for foetal emergencies, consent to caesarean section by the patient and consent from surgeon to allow the safe interruption of the routine surgery to provide access to perform emergency delivery. [6] Fukuda et al. reported utility of intraoperative FHR monitoring for cerebral arteriovenous malformation surgery during pregnancy in different trimesters: TEE (during the 2 nd trimester) and cardiotocography (during the 3 nd trimester) to avoid adverse effects of systemic maternal hypotension and unexpected bleeding on the foetus during surgery. [7] We have demonstrated continuous foetal monitoring with TEE probe intraoperatively in the lateral position. Intraoperative use of the TEE probe for foetal monitoring in pregnant patients has few distinct advantages over foetal tococardiography and Doppler transducer devices as it allows continuous beat-to-beat monitoring of heart rate and hands-free operation without need to engage any additional personnel. On account of its length, narrow and small probe surface, the TEE probe could easily be attached to the abdominal wall. This monitoring helped us intraoperatively in assessing the foetal well-being. Nevertheless despite foetal monitoring in the perioperative period, the child was subsequently born with low Apgar scores. The cause of this poor foetal outcome can be multifactorial. We conclude that continuous FHR monitoring in pregnant patients using the TEE probe intraoperatively is a useful addition to the armamentarium of the anaesthesiologist.
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Grissinger described two cases who were discharged home with fentanyl patch prescription. The first was a post-operative patient who died due to overdose. The second patient was brought to emergency room but did not have any adverse consequences. [2] In spite of this, a lot of research articles are getting published in peer-reviewed journals describing the use of fentanyl patches for post-operative analgesia after getting approval from the Local Ethics Committee or Institutional Review Board.
The kinetics of absorption of an opioid patch is not predictable. The onset of action can take several hours depending on the body temperature, previous dosing of opioid and factors such as site of application, haemodynamics and general condition of the patient (emaciation, hypovolaemia). Similarly, after the patch is removed, the absorption continues in an unpredictable manner for several hours. [3] Due to slow onset of action, patients are asked to apply the patch on the day before surgery which is not justified. Cutaneous blood flow at the site of patch influences Transdermal fentanyl patch in post-operative patients: Is it justified?
Sir, Fentanyl patches are approved by the United States-Food and Drug Administration (US-FDA) for patients who are opioid resistant. Patients who are suffering from moderate to severe pain even when they are using continuous, round-the-clock opioid medications for more than a week are called opioid resistant. Fentanyl is a Schedule II opioid agonist, i.e., it has a potential for abuse and could lead to serious respiratory depression. [1] Fentanyl transdermal patches are not indicated in acute post-operative pain due to the risk of serious, life-threatening respiratory depression and at times death, which is clearly mentioned as an important warning by the drug manufacturers themselves.
